AbbVie (NYSE:ABBV) continues to navigate the challenges of Humira's loss of exclusivity while leveraging its diverse portfolio and robust pipeline to drive future growth. With a gross profit margin of ...

AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company with a market capitalization of $311.86 billion, has been at the forefront of the industry with its diverse portfolio of pharmaceuticals ...

Watch Tim Robinson meet an alien, Charli XCX explain football, and Post Malone pound some brews.

Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.

Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's ...

AbbVie closed out the year on a high note as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s final monthly ranking of the biggest TV ad spenders in biopharma.

After what some real estate experts are calling a capital crisis, momentum in Saskatchewan and Canada’s commercial real estate investment market is finally bouncing back. “Interest rates have ...

Blackstone President Jon Gray said at the time that he believes the extreme distress the commercial real estate market has faced in recent years is beginning to ease up. He now sees opportunity in ...

Sanofi and Regeneron’s Dupixent, AbbVie’s Skyrizi, Gilead Sciences' Biktarvy and J&J’s Darzalex rounded out the list of top drugs by projected sales this year. Lilly looks to 'protect its ...

The launchers will compete for contracts to launch satellites for China’s megaconstellation projects—Thousand Sails and Guowang—space station cargo missions and commercial and other ...

Survive until '25. Commercial property investors hung on to the echo of an old Sam Zell mantra over the past year as the public health crisis faded further in the rearview mirror and hope grew for ...